Transaction DateRecipientSharesTypePriceValue
27th October 2020Walter S Woltosz24,000Open or private sale$68.95$1,654,800.00
24th September 2020Walter S Woltosz24,000Open or private sale$66.08$1,585,920.00
26th August 2020Walter S Woltosz24,000Open or private purchase$58.16$1,395,840.00
3rd August 2020Walter S Woltosz206Grant/award etc.$72.09$14,850.54
3rd August 2020John Kenneth Paglia206Grant/award etc.$70.40$14,502.40
3rd August 2020Daniel L Weiner206Grant/award etc.$70.40$14,502.40
3rd August 2020David L. Ralph206Grant/award etc.$70.40$14,502.40
3rd August 2020Lisa La Vange206Grant/award etc.$70.40$14,502.40
27th July 2020Walter S Woltosz24,000Open or private sale$66.13$1,587,120.00
24th June 2020Walter S Woltosz24,000Open or private sale$55.82$1,339,680.00
Simulations Plus
Simulations Plus logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.


Simulations Plus, Inc. engages in licensing and conducting drug research by pharmaceutical and biotechnology companies. It offers pharmaceutical, and chemical, cosmetics and food industries. The company was founded by Walter S. Woltosz and Virginia E. W Holtosz on July 17, 1996.


Ticker: SLP
Sector: Technology Services
Industry: Packaged Software
SEC Central Index Key (CIK): 1023459
Employees: 111
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals